These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Reduced graphene oxide-ZnO nanocomposite based electrochemical sensor for sensitive and selective monitoring of 8-hydroxy-2'-deoxyguanosine.
    Author: Hao J, Wu K, Wan C, Tang Y.
    Journal: Talanta; 2018 Aug 01; 185():550-556. PubMed ID: 29759240.
    Abstract:
    Developing reliable and feasible electrochemical sensors for the detection of 8-hydroxy-2'-deoxyguanosine (8-OHdG) is important because the urinary level of 8-OHdG is related to cancer disease. Moreover, the co-existed uric acid (UA) as an interference severe affects the sensitive detection of 8-OHdG. Herein, sensitive monitoring of 8-OHdG was conducted using a nanocomposite of reduced graphene oxide (rGO) and ZnO nanoparticles (ZnO@rGO) as the sensing material. This nanocomposite was prepared via in-situ reduction of GO with Zn powders. Compared with those obtained on the unmodified glassy carbon electrode (GCE) and GO modified GCE (GO/GCE) the oxidation signals of 8-OHdG are significantly enhanced on the ZnO@rGO nanocomposite coated GCE (ZnO@rGO/GCE). Moreover, uricase has been employed successfully to eliminate the interferences of UA. A large amount of UA did not affect the oxidation signals of trace level of 8-OHdG. The linear range for the detection of 8-OHdG using ZnO@rGO/GCE was from 5.0 to 5000.0 nM. The detection limit was 1.25 nM calculated from a three-signal-to-noise ratio. The developed monitoring system is sensitive and selective for the determination of 8-OHdG and thus useful in practical applications, such as for the monitoring of 8-OHdG in the clinic urine samples.
    [Abstract] [Full Text] [Related] [New Search]